xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05997537</url>
    </required_header>
    <id_info>
      <org_study_id>Pro00056067</org_study_id>
      <nct_id>NCT05997537</nct_id>
    </id_info>
    <brief_title>Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD</brief_title>
    <official_title>Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Cedars-Sinai Medical Center</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Cedars-Sinai Medical Center</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        To understand patient knowledge, attitudes, and beliefs around the uptake of vaccinations and&#xD;
        malignancy screening through patient focus groups/qualitative interviews. To develop and&#xD;
        pilot an interactive website that will provide customized recommendations for individual&#xD;
        patients with IBD and direct them as relevant to five 60-90 second customized, animated&#xD;
        videos (influenza, pneumococcal, and zoster vaccinations, bone health, and skin cancer&#xD;
        screening). This content will be pilot-tested with patients to fine-tune the educational&#xD;
        modules.&#xD;
      </textblock>
    </brief_summary>
    <overall_status>Completed</overall_status>
    <start_date type="Actual">February 25, 2019</start_date>
    <completion_date type="Actual">March 7, 2022</completion_date>
    <primary_completion_date type="Actual">March 7, 2022</primary_completion_date>
    <study_type>Observational</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <observational_model>Cohort</observational_model>
      <time_perspective>Prospective</time_perspective>
    </study_design_info>
    <primary_outcome>
      <measure>Uptake of influenza vaccination</measure>
      <time_frame>Through study completion, no later than March 31, 2020</time_frame>
      <description>Uptake of influenza vaccination</description>
    </primary_outcome>
    <enrollment type="Actual">1056</enrollment>
    <condition>IBD</condition>
    <eligibility>
      <study_pop>
        <textblock>
          Patients enrolled in IBD Partners, age 18 and older who have agreed to be contacted for&#xD;
          future studies.&#xD;
        </textblock>
      </study_pop>
      <sampling_method>Probability Sample</sampling_method>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  enrollees in the internet-based cohort IBD Partners, age 18 and older&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
          -&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Gil Melmed, MD</last_name>
      <role>Principal Investigator</role>
      <affiliation>Cedars-Sinai Medical Center</affiliation>
    </overall_official>
    <location>
      <facility>
        <name>Cedars-Sinai</name>
        <address>
          <city>Los Angeles</city>
          <state>California</state>
          <zip>90048</zip>
          <country>United States</country>
        </address>
      </facility>
    </location>
    <location_countries>
      <country>United States</country>
    </location_countries>
    <verification_date>August 2023</verification_date>
    <study_first_submitted>August 4, 2023</study_first_submitted>
    <study_first_submitted_qc>August 15, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 18, 2023</study_first_posted>
    <last_update_submitted>August 15, 2023</last_update_submitted>
    <last_update_submitted_qc>August 15, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 18, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
      <investigator_full_name>Gil Melmed</investigator_full_name>
      <investigator_title>Clinical Director of Inflammatory Bowel Disease</investigator_title>
    </responsible_party>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05997537
  org study id: Pro00056067
  nct id: NCT05997537
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  To understand patient knowledge, attitudes, and beliefs around the uptake of vaccinations and
        malignancy screening through patient focus groups/qualitative interviews. To develop and
        pilot an interactive website that will provide customized recommendations for individual
        patients with IBD and direct them as relevant to five 60-90 second customized, animated
        videos (influenza, pneumococcal, and zoster vaccinations, bone health, and skin cancer
        screening). This content will be pilot-tested with patients to fine-tune the educational
        modules.
  observational model: Cohort
  time perspective: Prospective
  measure: Uptake of influenza vaccination
  time frame: Through study completion, no later than March 31, 2020
  description: Uptake of influenza vaccination
  study pop: 
  sampling method: Probability Sample
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: N/A
  healthy volunteers: No
  last name: Gil Melmed, MD
  role: Principal Investigator
  affiliation: Cedars-Sinai Medical Center
  facility: 
  country: United States
  responsible party type: Principal Investigator
  investigator affiliation: Cedars-Sinai Medical Center
  investigator full name: Gil Melmed
  investigator title: Clinical Director of Inflammatory Bowel Disease